Pinteon Therapeutics

0 followers


Pinteon Therapeutics is advancing clinical studies of a novel antibody that aims to interrupt the spread of toxic tau and protect and preserve brain function in patients with neurodegenerative disease.

Industries

Headquarters

Stage

Employees

Links

Org chart

Martin Jefson

Collapse
Michael Ahlijanian
Chief Scientific Officer
Larry Altstiel
Chief Medical Officer
Wendy Luca
Senior Director of Clinical Operations
Kelly Foster
VP of Biology
Kim McClure
VP of Chemistry